NCT04214262 2026-03-18
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Yantai LNC Biotechnology Singapore PTE. LTD.
Shanghai Chest Hospital
Maastricht Radiation Oncology